NUS
NU SKIN ENTERPRISES, INC.
Key Financials
Net Income
$160.2M
↑ 209.3%
Operating Income
$65.8M
↑ 143.4%
Revenue
$1.5B
↓ 14.3%
Gross Profit
$1.0B
↓ 12.7%
EPS (Diluted)
$3.18
↑ 207.8%
Total Assets
$1.4B
↓ 4.3%
Shareholders' Equity
$805.2M
↑ 23.6%
Total Liabilities
$600.1M
↓ 26.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/14/2026 | View on SEC |
| 4 | 5/12/2026 | View on SEC |
| 144 | 5/11/2026 | View on SEC |
| 8-K | 5/8/2026 | View on SEC |
| 10-Q | 5/8/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| ARS | 4/3/2026 | View on SEC |
| DEFA14A | 4/3/2026 | View on SEC |
| DEF 14A | 4/3/2026 | View on SEC |
| 3 | 3/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NUS |
| Company Name | NU SKIN ENTERPRISES, INC. |
| CIK | 1021561 |
| Sector | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Industry | Accelerated filer |
| Exchange | NYSE |
| SIC Code | 5122 |
| SIC Description | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 801-345-1000 |